| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-10 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |